Bayer, J&J Minimized Drug Reaction Data, 3rd Circ. Told
By Carla Baranauckas · January 17, 2025, 9:21 PM EST
A doctor urged the Third Circuit on Friday to revive his whistleblower suit against Bayer Corp. and Johnson & Johnson, arguing that the drugmakers' regulatory approval applications played down the side...
To view the full article, register now.